Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

12 resultados carregados na pagina 5 para "still"
Arsenal step up push for defensive cover with Timber and Saliba sidelined
Arsenal step up push for defensive cover with Timber and Saliba sidelined
Gunners expected to return with fresh bid for KonsaArteta says existing players need to step up for nowArsenal are stepping up their efforts to sign defensive cover for William Saliba after Mikel Arteta revealed that Jurriën Timber is still “weeks away” from returning to competit
We Don't Talk Enough About AURALEE's Great Left-Field Fabrics
We Don't Talk Enough About AURALEE's Great Left-Field Fabrics
AURALEE's clothes are deservingly loved around the world but the fabrics that define its garments are still all too underrated.
The secret lives of theatre workers: ‘People were having full sex in the stalls’
The secret lives of theatre workers: ‘People were having full sex in the stalls’
Domestic dramas, bodily fluids, drink, drugs, rudeness and worse … ushers and box office staff have seen it all. So much for the myth of the ‘genteel’ theatregoer‘Theatre still has a sheen of respectability, so people feel they can behave badly because where they are cancels out
Defiant Hodgkinson says home European title would mean as much as Olympic gold
Defiant Hodgkinson says home European title would mean as much as Olympic gold
Keely Hodgkinson will seek to prove she is still number one following a "tricky" outdoor season when she faces world-class rivals for European 800m gold in Birmingham.
McInnes left frustrated amid Rangers' poor start to season
McInnes left frustrated amid Rangers' poor start to season
Derek McInnes is still seeking a win after three games as Rangers managers and feels hard done by following a 2-1 home defeat by Hibernian and injury to big-money striker Youssef Chermiti.
Embattled hedge fund Situational Awareness invests $400M in chip startup Source Foundry
Embattled hedge fund Situational Awareness invests $400M in chip startup Source Foundry
The AI-focused hedge fund is still making some big bets. O recorte ajuda a contextualizar a pauta dentro de Tech.
Gaza’s children still struggling with hunger as another famine threatens
Gaza’s children still struggling with hunger as another famine threatens
Youngsters are still feeling the effects of the 2025 famine, with another food emergency emerging. O recorte ajuda a contextualizar a pauta dentro de Geral.
Hibs win at Rangers as McInnes remains winless
Hibs win at Rangers as McInnes remains winless
Derek McInnes is still looking for his first win as Rangers manager after Hibernian netted an injury-time winner to triumph 2-1 at Ibrox.
World number one Sinner to miss Cincinnati Open
World number one Sinner to miss Cincinnati Open
World number one Jannik Sinner withdraws from this week's Cincinnati Open because of a knee injury, but still expects to be fit for the US Open later this month.
Foto: Bob Jenkin / Pexels
How to explore Britain and Ireland’s most beautiful rivers on foot, bike or boat: readers’
Our rivers may be running low at the moment, but they still offer an abundance of adventure and nature to explore. Here are your favourites, from the Tees to the Shannon • Tell us about a favourite holiday in the UK – the best tip wins a £200 holiday voucherLast summer, I enjoyed
Foto: Stephen Leonardi / Pexels
Tanker sailors still face danger in the Strait of Hormuz
An agreement over the Strait of Hormuz is still far away. Tim Wilkins, who works for a tanker industry group, says the ships stuck around the waterway are in limbo, and transiting is still dangerous.
Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines
Drug spending increasingly rewards pharmaceutical innovation over 'me-too' medicines
A long-running debate over prescription drug costs has centered on whether drug manufacturers are better rewarded for truly innovative medicines or so-called "me-too" drugs that may offer only incremental improvements over existing treatments but still command high prices.